INTERNATIONAL PATENT: DECARITAS BIOTECH INC., 주식회사 데카리타스바이오텍 FILES APPLICATION FOR "USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FIBROSIS USING INHIBITION OF TGF-BETA SIGNALING AND PROMOTION OF AUTOPHAGY"

GENEVA, May 5 -- DECARITAS BIOTECH INC. (J783, 2 Floor, 47, Gangnam-daero 112-gil,Gangnam-gu,Seoul 06121), 주식회사 데카리타스바이오텍 (서울특별시강남구강남대로112길 47, 2층-제이783호) filed a patent application (PCT/KR2025/016759) for "USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FIBROSIS USING INHIBITION OF TGF-BETA SIGNALING AND PROMOTION OF AUTOPHAGY" on Oct 21, 2025. With publication no. WO/2026/089461, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submi...